Tanaka Naoko, Kawasaki Kumiko, Nejime Namie, Kubota Yoko, Nakamura Kazuki, Kunitomo Masaru, Takahashi Koichi, Hashimoto Michio, Shinozuka Kazumasa
Department of Pharmacology, School of Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan.
J Pharmacol Sci. 2004 Jun;95(2):174-80. doi: 10.1254/jphs.fpj03036x.
We investigated the effects of P2-receptor agonists on cell size, intracellular calcium levels (Ca(2+)), and permeation of FITC-labeled dextran (FD-4) as well as the relationship between these effects in human umbilical vein endothelial cells (HUVEC). FD-4 concentration, cell size, and Ca(2+) were analyzed by HPLC with fluorescence, phase contrast microscopic imaging, and fluorescent confocal microscopic imaging, respectively. The P2Y(1)-receptor agonists 2-methylthio ATP (2meS-ATP) and ADP decreased cell size and increased Ca(2+) in HUVEC. The P2Y(2)-receptor agonist UTP increased Ca(2+), but did not influence cell size. The P2X-receptor agonist alpha,beta-methylene ATP did not induce either response. The decrease in size and increase in Ca(2+) by 2meS-ATP were blocked by pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS, P2Y(1)-antagonist), thapsigargin (Ca(2+)-pump inhibitor), and U73122 (phospholipase C inhibitor). Furthermore, 2meS-ATP (P2Y(1)-receptor agonist) enhanced permeation of FD-4 through the endothelial cell monolayer. The 2meS-ATP-induced enhancement of the permeation was also prevented by PPADS, thapsigargin, and U73122. These results indicate that activation of P2Y receptors induces a decrease in cell size, an increase in Ca(2+), and may participate in facilitating macromolecular permeability in HUVEC.
我们研究了P2受体激动剂对人脐静脉内皮细胞(HUVEC)的细胞大小、细胞内钙水平([Ca(2+)]i)、FITC标记葡聚糖(FD-4)的通透作用以及这些作用之间的关系。分别采用荧光HPLC、相差显微镜成像和荧光共聚焦显微镜成像分析FD-4浓度、细胞大小和[Ca(2+)]i。P2Y(1)受体激动剂2-甲硫基ATP(2meS-ATP)和ADP可减小HUVEC的细胞大小并升高[Ca(2+)]i。P2Y(2)受体激动剂UTP可升高[Ca(2+)]i,但不影响细胞大小。P2X受体激动剂α,β-亚甲基ATP未引发上述任何一种反应。2meS-ATP导致的细胞大小减小和[Ca(2+)]i升高被磷酸吡哆醛-6-偶氮苯基-2',4'-二磺酸(PPADS,P2Y(1)拮抗剂)、毒胡萝卜素(钙泵抑制剂)和U73122(磷脂酶C抑制剂)所阻断。此外,2meS-ATP(P2Y(1)受体激动剂)可增强FD-4透过内皮细胞单层的通透作用。PPADS毒胡萝卜素和U73122也可阻止2meS-ATP诱导的通透增强作用。这些结果表明,P2Y受体的激活可导致细胞大小减小、[Ca(2+)]i升高,并可能参与促进HUVEC中大分子的通透性。